In February 2023, Mitsubishi Chemical Group announced its decision to stop Medicago Inc.’s operations. Medicago was a pharmaceutical company based in Quebec, Canada that made headlines at the height of the COVID-19 pandemic when it successfully used plant molecular farming to create COVIFENZ® COVID-

Related Keywords

Canada ,Israel ,Bangkok ,Krung Thep Mahanakhon ,Thailand ,United States ,Quebec ,Brazil ,Iceland ,Italy ,United Kingdom ,Israeli ,Baiya Phytopharm ,Zabrinaj Bugnosen ,Mitsubishi Chemical Group ,University Of Verona ,Animal Health ,Israel Ministry Of Health ,Medicago Inc Nature Biotechnology ,University Of Louisville ,Medicago To Cease Operations Mitsubishi Chemical Group ,Health Canada Approves ,Drug Administration ,International Journal Of Molecular Sciences ,Medicago Inc ,Plant Biotechnology ,Plant Viruses ,Tobacco Mosaic Virus ,Cowpea Mosaic Virus ,Cowpea Chlorotic Mottle Virus ,Brome Mosaic ,Swine Fever Green Marker Main Vaccine ,Human Immunodeficiency Virus ,Icon Genetics ,Its Expresstec ,Bio Pharms ,South Africa ,Nature Biotechnology ,Molecular Farming ,International Journal ,Molecular Sciences ,Vaccine Candidate ,Using Proprietary Plant Based Technology ,Consolidated Subsidiary ,Cease Operations ,Efforts Using Plant Technologies ,Science Speaks ,